Summary
Machine-generated summaryThe Czech contracting authority is procuring recurring deliveries of medicinal products for the prevention and treatment of bleeding in haemophilia A, namely recombinant factor VIII with an extended biological half-life (Esperoct). The procurement is divided into five parts covering: treated patients aged 13 and over previously treated with plasma-derived or recombinant FVIII for at least 150 exposure days; previously untreated patients aged 13 and over; patients up to 12 years of age; and patients with haemophilia A with an inhibitor against FVIII (titre up to 5 BU), third generation or higher. All products must meet the requirements of the Czech medicines authority SUKL.
Description
5 lots
- Lot 1
- Koagulační faktor VIII - rekombinantní Esperoct pro rozléčené pacienty od 13 let kteří jsou předléčení FVIII z plazmy nebo rFVIII min 150 expozičních dní estimated €1,399,795 · 96 months
- Lot 2
- Hemofilie A-Koagulační faktor VIII - rekombinantní s delším biologickým poločasem- pro pacienty od 13 let kteří jsou předléčení FVIII z plazmy nebo rFVIII min 150 expozičních dní estimated €31,536 · 96 months
- Lot 3
- Hemofilie A-Koagulační faktor VIII - rekombinantní s delším biologickým poločasem - pro pacienty od 13 let bez předléčení FVIII z plazmy nebo rFVIII estimated €3,513,398 · 96 months
- Lot 4
- Hemofilie A-Koagulační faktor VIII - rekombinantní s delším biologickým poločasem-pro pacienty do 12 let estimated €26,296 · 96 months
- Lot 5
- Rekombinantní přípravky na prevenci a léčbu krvácení u hemofilie A, dále u nemocných hemofilií A s inhibitorem proti FVIII (titr do 5 BU) 3. a vyšší generace estimated €30,911 · 96 months
- How tenders are scored
- Celková nabídková cena v Kč bez DPH: 100 percent
- Small firms
- The buyer marks this procedure as suitable for small and medium-sized firms.
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago
The buyer
Full buyer profileFakultní nemocnice Olomouc
- notices in the register
- 1,296
- awards
- 695
- awarded in total
- €1.1B
Who wins its contracts
Many suppliers- different companies won its awards
- 255
- of the awards went to the three most frequent winners
- 19%
- of its calls state an estimated value
- 89%
Based on 596 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.6
- of those lots received a single tender
- 60%
- of the awards went to companies based in another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
40 open tenders right now
- Antineoplastics and immunomodulators - Framework agreement with lenvatinib content 2026 1 day left
- Czech Republic - Medical absorbent material - Non-woven sterile compresses 1 day left
- Czech Republic - Vehicles for patient transport - University Hospital Olomouc - purchase of ambulances 2026 1 day left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,281
- median open notice
- €306,699
Who wins in this market
Many suppliersCzechia · Medical equipment & pharmaceuticals
- different companies won awards here
- 1,137
- of the awards went to the three most frequent winners
- 19%
- buyers awarded contracts here
- 173
Based on 4,860 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.6
- of those lots received a single tender
- 61%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
11
days left
€2,253,575
est. value
15
days left
€4,365,291
est. value
8
days left
€1,001,785
est. value
Awarded before
Never miss a tender like this
169 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Medicinal products for the blood and blood-forming organs: an email when new tenders arrive under it, no account needed.